Harnessing Human-Derived Proteomics & Multi-Omics to Drive Modality-Specific Target Discovery, Target-Pair Selection & Therapeutic Development
8:59 am - Thursday 10th December 2026
Hanson Wade Group have taken the decision to cancel this meeting. Please do accept our apologies for any inconvenience or disappointment this will cause.
8:59 am - Thursday 10th December 2026